Fueling Innovation
Researchers spend hours writing grants to compete for funding. This is precious time that could be spent in the lab. With a Paceline grant, researchers are able to purchase equipment, test theories, and move more discoveries forward. Thanks to the support of our partners, Paceline is able to give 100% of the funds you raise to researchers at the Georgia Cancer Center.
|
Dr. Nagendra Singh UFL1 and immune checkpoint blockade |
“Targeting RXRα signaling network in combination with immunotherapy to induce robust antitumor immune responses” |
“Epithelial-stromal cell interactions as drivers of precancer progression to cancer: application of single-cell transcriptomics in longitudinally-sampled oral precancer” |
|
“The Study of Colorectal Cancer Risk Perceptions and Outcomes among Early-Onset Colorectal Cancer Survivors” |
Dr. Upasana Sahu “Development of a next generation oncolytic HSV for dual targeting of AKT and ERK signaling in glioblastoma” |
Sara Murphy “Antibody targeting CD73 augments oncolytic herpes virus efficacy in glioblastoma” |
|
“Targeting immunosuppressive M2 macrophages by engineered exosomes to control metastatic growth of breast cancers and improve survival” |
“Unleashing anti-tumor immunity against TNBC through inhibition of the cochaperone UNC45A and activation of the STING pathway” |
Dr. Yukai He and Dr. Siva Panda “Armor CAR-Ts to improve tumor infiltration and antitumor effects” |
|
“The role of tumor microenvironment adenosine in hindering antitumor immunity in spatial context” |
“The development of a comprehensive colorectal cancer database in the Augusta-Richmond County, Georgia” |
Dr. Bangxing Hong “Reversing IDO signaling activation during oncolytic virotherapy of pediatric high-grade glioma” |
|
Dr. David Mysona “Utilization of artificial intelligence to predict the development of financial toxicity in gynecologic oncology” |
Dr. Pankaj Ahluwalia “Investigating the genomics of normal adjacent tumor (NAT) to understand the immunotherapy resistance in solid tumors” |
Mercy Kehinde-Ige “Investigating the effects of Stat5a on metabolism in CASTAT5-CD4+ T cells for adoptive cell therapy” |
|
“Racial Disparities in Food Deserts, Food Swamps, and Multiple Cancer Outcomes: A Mixed Methods Analysis” |
Dr. Yukai He “Developing novel intermediate-avidity CAR-Ts for hepatocellular carcinoma immunotherapy” |
Dr. Tianxiang Hu “BCR-ABL1 isoforms in reshaping the leukemic immune microenvironment and contributions to leukemia progression” |
|
Dr. Hasan Korkaya “Development of novel HSP70 small molecule peptidomimetic inhibitors in syngeneic models of breast cancer” |
“Determine the Potential of Targeting Heat Shock Factor HSF1 in Acute Myelogenous Leukemia” |
“Mobile Cancer Molecular Biology Lab Experience for Local High School Outreach” |
|
Dr. John Henson Translational Disparities Research Award |
Dr. Tianxiang Hu Early Career Researcher Award |
|
Dr. Han-Fei Ding Major Equipment Award |
Dr. Huidong Shi & Ravindra Kolhe Translational Research Award |
Dr. Zhi-Chun Ding Early Career Researcher Award |